| Literature DB >> 33062815 |
Nazanin Mahdavi1, Pouyan Aminishakib1, Nika Soltani2.
Abstract
STATEMENT OF THE PROBLEM: Oral lichen planus (OLP) is a chronic inflammatory disease with unknown etiopathogenesis. It was believed that T cells played the major role in developing the lesions. It has been recently suggested that B lymphocyte cells (B cells) and plasma cells may play a role in OLP pathogenesis.Entities:
Keywords: B cell; Oral lichen planus; Pathogenesis; Plasma cell
Year: 2020 PMID: 33062815 PMCID: PMC7519941 DOI: 10.30476/DENTJODS.2020.81804.0
Source DB: PubMed Journal: J Dent (Shiraz) ISSN: 2345-6418
Expression of CD20 and CD138 in OLPs (Oral lichen planus)
| Min (%) | Max (%) | Mean (%) | Expression by grade | ||
|---|---|---|---|---|---|
| CD20 expression | 2 | 80 | 22.5±15.17 | Grade 1 | 0 |
| Grade 2 | 56(91.8%) | ||||
| Grade 3 | 5(8.2%) | ||||
| CD138 expression | 0 | 41 | 4.74±9.23 | Grade 1 | 23(37.7%) |
| Grade 2 | 38(62.3%) | ||||
| Grade 3 | 0 | ||||
Figure 1CD20 immuno-expression (×200).
Figure 2CD138 immuno-expression in lymphocytic infiltration and epithelium as internal positive control (200×).
Prevalence of clinical subtypes, histopathological features and their correlation with CD20 and CD138 expression.
| Number of specimens | Grade of CD138 staining intensity | Grade of CD20 staining intensity | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Grade 1 | Grade 2 | Grade 3 | Grade 1 | Grade 2 | Grade 3 | ||||
| Type of lesion | |||||||||
| Reticular | 45(73.8%) | 16(26.2%) | 29(47.5%) | 0 | 0.559 | 0 | 42(68.9%) | 3(4.9) | 0.522 |
| Erosive/atrophic | 13(21.3%) | 5(8.2%) | 8(13.1%) | 0 | 0 | 11(18%) | 2(3.3%) | ||
| Bullous | 3(4.9%) | 2(3.3%) | 1(1.6%) | 0 | 0 | 3(4.9%) | 0 | ||
| Site of lesion | |||||||||
| Buccal mucosa | 51(83.6%) | 17(27.9%) | 31(55.7%) | 0 | 0.345 | 0 | 46(75.4%) | 5(8.2%) | 0.785 |
| Tongue | 7(11.5%) | 4(6.6%) | 3(4.9%) | 0 | 0 | 7(11.5%) | 0 | ||
| Gum | 2(3.3%) | 1(1.6%) | 1(1.6%) | 0 | 0 | 2(3.3%) | 0 | ||
| Palate | 1(1.6%) | 1(1.6%) | 0 | 0 | 0 | 1(1.6%) | 0 | ||
| Keratosis | |||||||||
| Parakeratosis | 41(67.2%) | 15(24.6%) | 26(42.6%) | 0 | 0.75 | 0 | 39(63.9%) | 5(8.2%) | 0.004* |
| Orthokeratosis | 5(8.2%) | 1(1.6%) | 4(6.6%) | 0 | 0 | 3(4.9%) | 0 | ||
| Both | 13(21.3%) | 6(9.8%) | 7(11.5%) | 0 | 0 | 13(21.3%) | 0 | ||
| No | 2(3.3%) | 1(1.6%) | 1(1.6%) | 0 | 0 | 1(1.6%) | 0 | ||
| Acanthosis | |||||||||
| Yes | 13(21.3%) | 4(6.6%) | 9(14.8%) | 0 | 0.749 | 0 | 12(19.7%) | 1(1.6%) | 1.000 |
| No | 48(78.7%) | 19(31.1%) | 29(47.5%) | 0 | 0 | 44(72.1%) | 4(6.6%) | ||
| Granulosis | |||||||||
| Yes | 25(41%) | 13(21.3%) | 12(19.7%) | 0 | 0.066 | 0 | 22(36.1%) | 3(4.9%) | 0.392 |
| No | 36(59%) | 10(16.4%) | 26(42.6%) | 0 | 0 | 34(55.7%) | 2(3.3%) | ||
| Spongiosis | |||||||||
| Yes | 8(13.1%) | 2(3.3%) | 6(9.8%) | 0 | 0.698 | 0 | 7(11.5%) | 1(1.6%) | 0.518 |
| No | 53(86.9%) | 21(34.4%) | 32(52.5%) | 0 | 0 | 49(80.3%) | 4(6.6%) | ||
| Lymphocyte exocytosis | |||||||||
| Yes | 16(26.2%) | 6(9.8%) | 10(16.4%) | 0 | 1.000 | 0 | 15(24.6%) | 1(1.6%) | 1.000 |
| No | 45(73.8%) | 17(27.9%) | 28(45.9%) | 0 | 0 | 41(67.2%) | 4(6.6%) | ||
| Hydropic degeneration of basal layer | |||||||||
| Less than 25% | 4(6.6%) | 1(1.6%) | 3(4.9%) | 0 | 0.144 | 0 | 3(4.9%) | 1(1.6%) | 0.398 |
| 25%-50% | 9(14.8%) | 6(9.8%) | 3(4.9%) | 0 | 0 | 8(13.1%) | 1(1.6%) | ||
| More than 50% | 48(78.7%) | 16(26.2%) | 32(52.5%) | 0 | 0 | 45(73.8%) | 3(4.9%) | ||
| Epithelium separation | |||||||||
| Yes | 22(36.1%) | 7(11.5%) | 15(24.6%) | 0 | 0.586 | 0 | 19(31.1%) | 3(4.9%) | 0.341 |
| No | 39(63.9%) | 16(26.2%) | 23(37.7%) | 0 | 0 | 37(60.7%) | 2(3.3%) | ||
| Intensity of inflammatory infiltrative | |||||||||
| Mild | 40(65.6%) | 16(26.2%) | 24(39.3%) | 0 | 0.108 | 0 | 37(60.7%) | 3(4.9%) | 0.843 |
| Moderate | 19(31.1%) | 5(8.2%) | 14(23.0%) | 0 | 0 | 17(27.9%) | 2(3.3%) | ||
| Severe | 2(3.3%) | 2(3.3%) | 0 | 0 | 0 | 2(3.3%) | 0 | ||
| Dysplasia | |||||||||
| No | 46(75.4%) | 17(27.9%) | 29(47.5%) | 0 | 1.000 | 0 | 41(67.2%) | 5(8.2%) | 0.321 |
| Mild | 15(24.6%) | 6(9.8%) | 9(14.8%) | 0 | 0 | 0 | 0 | ||
| Moderate | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Severe | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| SCC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||